Skip to main contentSkip to navigationSkip to search
HNSA (, %) SEK
Hansa Biopharma logotype

Hansa Medical to present IdeS at the World Orphan Drug Congress USA, April 24 in Washington D.C.

The presentation focusing on Hansa Medical’s lead drug-candidate IdeS’ capacity for desensitization prior to kidney transplantation is scheduled for 3:15 pm on April 24.

The World Orphan Drug Congress USA will be held on April 23-25 at the Grand Hyatt Washington, Washington D.C. For more information about the event please visit:

The company presentation’s emphasize will be on its lead drug-candidate IdeS, IdeS’ recent clinical Phase I results and IdeS’ forthcoming Phase II studies in 2014.